59 related articles for article (PubMed ID: 15998093)
1. Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery.
Yinghuai Z; Peng AT; Carpenter K; Maguire JA; Hosmane NS; Takagaki M
J Am Chem Soc; 2005 Jul; 127(27):9875-80. PubMed ID: 15998093
[TBL] [Abstract][Full Text] [Related]
2. Boron rich nanotube drug carrier system is suited for boron neutron capture therapy.
Heide F; McDougall M; Harder-Viddal C; Roshko R; Davidson D; Wu J; Aprosoff C; Moya-Torres A; Lin F; Stetefeld J
Sci Rep; 2021 Jul; 11(1):15520. PubMed ID: 34330984
[TBL] [Abstract][Full Text] [Related]
3. Interaction between glycine/glycine radicals and intrinsic/boron-doped (8,0) single-walled carbon nanotubes: a density functional theory study.
Sun W; Bu Y; Wang Y
J Phys Chem B; 2008 Dec; 112(48):15442-9. PubMed ID: 19006275
[TBL] [Abstract][Full Text] [Related]
4. Macrophages as carriers of boron carbide nanoparticles dedicated to boron neutron capture therapy.
Wróblewska A; Szermer-Olearnik B; Szczygieł A; Węgierek-Ciura K; Mierzejewska J; Kozień D; Żeliszewska P; Kruszakin R; Migdał P; Pędzich Z; Pajtasz-Piasecka E
J Nanobiotechnology; 2024 Apr; 22(1):183. PubMed ID: 38622691
[TBL] [Abstract][Full Text] [Related]
5. Molecular engineering of AIE-active boron clustoluminogens for enhanced boron neutron capture therapy.
Ma W; Wang Y; Xue Y; Wang M; Lu C; Guo W; Liu YH; Shu D; Shao G; Xu Q; Tu D; Yan H
Chem Sci; 2024 Mar; 15(11):4019-4030. PubMed ID: 38487248
[TBL] [Abstract][Full Text] [Related]
6. The role of radiolabeling in BNCT tracers for enhanced dosimetry and treatment planning.
Mushtaq S; Ae PJ; Kim JY; Lee KC; Kim KI
Theranostics; 2023; 13(15):5247-5265. PubMed ID: 37908724
[TBL] [Abstract][Full Text] [Related]
7. In Vivo Application of Carboranes for Boron Neutron Capture Therapy (BNCT): Structure, Formulation and Analytical Methods for Detection.
Marforio TD; Carboni A; Calvaresi M
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894311
[TBL] [Abstract][Full Text] [Related]
8. Carboranes as unique pharmacophores in antitumor medicinal chemistry.
Chen Y; Du F; Tang L; Xu J; Zhao Y; Wu X; Li M; Shen J; Wen Q; Cho CH; Xiao Z
Mol Ther Oncolytics; 2022 Mar; 24():400-416. PubMed ID: 35141397
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable and Peroxidase-Mimetic Boron Oxynitride Nanozyme for Breast Cancer Therapy.
Zeng L; Han Y; Chen Z; Jiang K; Golberg D; Weng Q
Adv Sci (Weinh); 2021 Aug; 8(16):e2101184. PubMed ID: 34189868
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine.
Cai J; Hosmane NS; Takagaki M; Zhu Y
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066470
[TBL] [Abstract][Full Text] [Related]
11. Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In vivo Evaluation.
Pulagam KR; Gona KB; Gómez-Vallejo V; Meijer J; Zilberfain C; Estrela-Lopis I; Baz Z; Cossío U; Llop J
Molecules; 2019 Oct; 24(19):. PubMed ID: 31591329
[No Abstract] [Full Text] [Related]
12. Fe₃O₄ Nanoparticles for Complex Targeted Delivery and Boron Neutron Capture Therapy.
Dukenbayev K; Korolkov IV; Tishkevich DI; Kozlovskiy AL; Trukhanov SV; Gorin YG; Shumskaya EE; Kaniukov EY; Vinnik DA; Zdorovets MV; Anisovich M; Trukhanov AV; Tosi D; Molardi C
Nanomaterials (Basel); 2019 Mar; 9(4):. PubMed ID: 30935156
[TBL] [Abstract][Full Text] [Related]
13. Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy.
Farhood B; Samadian H; Ghorbani M; Zakariaee SS; Knaup C
Rep Pract Oncol Radiother; 2018; 23(5):462-473. PubMed ID: 30263016
[TBL] [Abstract][Full Text] [Related]
14. Sonochemical Synthesis of Small Boron Oxide Nanoparticles.
Ramachandran R; Jung D; Bernier NA; Logan JK; Waddington MA; Spokoyny AM
Inorg Chem; 2018 Jul; 57(14):8037-8041. PubMed ID: 29939022
[TBL] [Abstract][Full Text] [Related]
15. Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.
Li X; Wang X; Zhang J; Hanagata N; Wang X; Weng Q; Ito A; Bando Y; Golberg D
Nat Commun; 2017 Jan; 8():13936. PubMed ID: 28059072
[TBL] [Abstract][Full Text] [Related]
16. Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.
Li J; Sharkey CC; Huang D; King MR
Cell Mol Bioeng; 2015; 8(1):137-150. PubMed ID: 25798204
[TBL] [Abstract][Full Text] [Related]
17. Carbon nanotubes part II: a remarkable carrier for drug and gene delivery.
Karimi M; Solati N; Ghasemi A; Estiar MA; Hashemkhani M; Kiani P; Mohamed E; Saeidi A; Taheri M; Avci P; Aref AR; Amiri M; Baniasadi F; Hamblin MR
Expert Opin Drug Deliv; 2015 Jul; 12(7):1089-105. PubMed ID: 25613837
[TBL] [Abstract][Full Text] [Related]
18. Bio-mimicking of proline-rich motif applied to carbon nanotube reveals unexpected subtleties underlying nanoparticle functionalization.
Zhang Y; Jimenez-Cruz CA; Wang J; Zhou B; Yang Z; Zhou R
Sci Rep; 2014 Nov; 4():7229. PubMed ID: 25427563
[TBL] [Abstract][Full Text] [Related]
19. Delivery of therapeutic radioisotopes using nanoparticle platforms: potential benefit in systemic radiation therapy.
Zhang L; Chen H; Wang L; Liu T; Yeh J; Lu G; Yang L; Mao H
Nanotechnol Sci Appl; 2010 Dec; 3():159-70. PubMed ID: 24198480
[TBL] [Abstract][Full Text] [Related]
20. Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas.
Chandra S; Barth RF; Haider SA; Yang W; Huo T; Shaikh AL; Kabalka GW
PLoS One; 2013; 8(9):e75377. PubMed ID: 24058680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
